- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Adenocarcinoma in Singapore
Total 185 results
-
National University Hospital, SingaporeRecruitingAdenocarcinomas | Recurrent GynecologicalSingapore
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeCompletedCarcinoma of Urinary Bladder, SuperficialSingapore
-
PfizerCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
National University Hospital, SingaporeRecruitingMetastatic Pancreatic Ductal AdenocarcinomaSingapore
-
PfizerCompletedUrinary Bladder, Overactive | Prostatic Hyperplasia | Erectile DysfunctionSingapore
-
National University Hospital, SingaporeUnknownOvarian Clear Cell CarcinomaSingapore
-
National University Hospital, SingaporeUnknown
-
Singapore General HospitalCompleted
-
National University Health System, SingaporeCompletedFollicular Thyroid CancerSingapore
-
Singapore General HospitalUnknownPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Neuroendocrine TumorSingapore
-
National Cancer Centre, SingaporeRecruitingColorectal Cancer | Pancreatic AdenocarcinomaSingapore
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), SingaporeCompletedPancreatic CancerSingapore
-
National University Hospital, SingaporeNot yet recruitingCarcinoma, Hepatocellular | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal Cancer | GastroEsophageal CancerSingapore
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularSingapore
-
National Cancer Centre, SingaporeTerminated
-
National Cancer Centre, SingaporePerspectumCompleted
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeActive, not recruiting
-
National University Hospital, SingaporeTerminated
-
Lion TCR Pte. Ltd.RecruitingHepatocellular CarcinomaSingapore
-
National Cancer Centre, SingaporeSingapore General HospitalCompletedHepatocellular Carcinoma ResectableSingapore
-
SanofiCompletedHydronephrosis | Neurogenic BladderCanada, Poland, Russian Federation, Turkey, Bulgaria, India, Malaysia, Serbia, Slovakia, Taiwan, Estonia, Singapore
-
National Cancer Centre, SingaporeNanyang Technological University; Duke-NUS Graduate Medical School; MiRXES Pte... and other collaboratorsRecruitingHepatocellular CarcinomaSingapore
-
National Cancer Centre, SingaporeActive, not recruitingHepatoCellular CarcinomaSingapore
-
Tan Tock Seng HospitalAstraZeneca; Singapore Cancer Syndicate.Unknown
-
National University Hospital, SingaporeRecruitingAdvanced Hepatocellular CarcinomaSingapore
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolUnknownHepatocellular CancerSingapore
-
National University Hospital, SingaporeUnknownAdvanced/ Metastatic Hepatocellular CarcinomaSingapore
-
National Cancer Centre, SingaporeNanyang Technological University; Duke-NUS Graduate Medical School; MiRXES Pte... and other collaboratorsRecruitingLiver DiseasesSingapore
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
National Cancer Centre, SingaporeNational University Hospital, Singapore; Singapore General Hospital; Tan Tock... and other collaboratorsRecruiting
-
Singapore General HospitalUnknown
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Singapore Cancer SocietyTerminatedLiver Cirrhosis | Hepatitis | Hepatocellular Carcinoma | Normal VolunteersSingapore
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
ASLAN PharmaceuticalsCompletedCholangiocarcinomaTaiwan, Korea, Republic of, Singapore
-
pSiVida LimitedpSiOncology Private LimitedUnknown
-
SanofiCompletedNeurogenic Urinary BladderUnited States, France, Canada, Poland, Germany, Portugal, Spain, Turkey, Bulgaria, Estonia, India, Malaysia, Philippines, Russian Federation, Serbia, Singapore, Slovakia, Taiwan
-
National Cancer Centre, SingaporeBristol-Myers SquibbRecruitingHepatocellular Carcinoma | Colorectal Cancer | Liver Metastases | Colorectal Carcinoma | Hepatocellular CancerSingapore
-
Lion TCR Pte. Ltd.WithdrawnRecurrent Hepatocellular CarcinomaSingapore, China
-
National Cancer Centre, SingaporeHoffmann-La Roche; Sirtex Medical; Singapore Clinical Research InstituteRecruitingLocally Advanced Hepatocellular CarcinomaKorea, Republic of, Singapore
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
National University Health System, SingaporeCompletedThymic Carcinoid | Multiple Endocrine Neoplasia Type 1 (MEN-1)Singapore
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellSingapore, United States
-
National Cancer Centre, SingaporeSingapore Clinical Research InstituteCompletedHepatocellular CarcinomaSingapore, Malaysia, Philippines, Thailand
-
Sichuan Huiyang Life Science and Technology CorporationCompletedMelanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Colon CancerSingapore